CORVUS PHARMACEUTICALS INC (CRVS) Institutional Shareholders
CORVUS PHARMACEUTICALS INC (CRVS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $977.71M in CRVS holdings during the latest filing period.
Orbimed Advisors Llc is currently the largest disclosed institutional shareholder of CRVS tracked by InsiderSet, reporting ownership valued at approximately $104.82M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $95.01M, representing an estimated loss of -9.36% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 54% of the total disclosed CRVS value among the investors covered in this analysis. Major shareholders include Orbimed Advisors Llc, Blackrock, Inc., State Street Corp, and several other long-term asset managers with concentrated positions in CORVUS PHARMACEUTICALS INC (CRVS).
This page ranks the largest institutional CRVS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
165
Total Reported Value
$977.71M
Largest Holder
Orbimed Advisors Llc
Largest Position
$104.82M
Insider Transactions (90d)
3
Latest Filing Quarter
Q2 2026
New Institutional Positions
195
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Orbimed Advisors Llc | 2.29% | 7,165,006 | $104,824,038 | $95,007,980 | -$9,816,058 | -9.36% | |
| Blackrock, Inc. | 0.00% | 6,160,422 | $90,126,972 | $81,687,196 | -$8,439,776 | -9.36% | |
| State Street Corp | 0.00% | 3,565,992 | $52,170,463 | $47,285,054 | -$4,885,409 | -9.36% | |
| Adams Street Partners Llc | 18.41% | 3,275,616 | $47,922,262 | $43,434,668 | -$4,487,594 | -9.36% | |
| Vanguard Capital Management Llc | 0.00% | 3,234,538 | $47,321,291 | $42,889,974 | -$4,431,317 | -9.36% | |
| Vivo Capital, Llc | 3.43% | 2,805,816 | $41,049,088 | $37,205,120 | -$3,843,968 | -9.36% | |
| Morgan Stanley | 0.00% | 2,498,825 | $36,557,808 | $33,134,420 | -$3,423,389 | -9.36% | |
| Deep Track Capital, Lp | 0.75% | 2,491,539 | $36,451,216 | $33,037,807 | -$3,413,409 | -9.36% | |
| Wellington Management Group Llp | 0.01% | 2,318,517 | $33,919,904 | $30,743,535 | -$3,176,369 | -9.36% | |
| Perceptive Advisors Llc | 0.66% | 2,292,441 | $33,538,412 | $30,397,768 | -$3,140,644 | -9.36% | |
| Commodore Capital Lp | 1.91% | 2,258,735 | $33,045,293 | $29,950,826 | -$3,094,467 | -9.36% | |
| Foresite Capital Management Vi Llc | 5.82% | 1,831,233 | $26,790,939 | $24,282,150 | -$2,508,789 | -9.36% | |
| Braidwell Lp | 0.86% | 1,752,798 | $25,643,435 | $23,242,101 | -$2,401,334 | -9.36% | |
| Geode Capital Management, Llc | 0.00% | 1,712,741 | $25,064,026 | $22,710,946 | -$2,353,080 | -9.39% | |
| Mpm Bioimpact Llc | 1.89% | 1,674,875 | $24,503,421 | $22,208,843 | -$2,294,579 | -9.36% | |
| Goldman Sachs Group Inc | 0.00% | 1,540,809 | $22,542,036 | $20,431,127 | -$2,110,909 | -9.36% | |
| Hood River Capital Management Llc | 0.20% | 1,335,109 | $19,532,645 | $17,703,545 | -$1,829,100 | -9.36% | |
| Boxer Capital Management, Llc | 2.11% | 1,100,000 | $16,093,000 | $14,586,000 | -$1,507,000 | -9.36% | |
| Polar Capital Holdings Plc | 0.07% | 1,070,174 | $15,656,646 | $14,190,507 | -$1,466,139 | -9.36% | |
| Catalio Capital Management, Lp | 2.73% | 891,933 | $13,048,980 | $11,827,032 | -$1,221,948 | -9.36% | |
| Millennium Management Llc | 0.01% | 866,362 | $12,674,876 | $11,487,960 | -$1,186,916 | -9.36% | |
| Adage Capital Partners Gp, L.L.C. | 0.02% | 750,000 | $10,972,500 | $9,945,000 | -$1,027,500 | -9.36% | |
| Emerald Advisers, Llc | 0.32% | 686,216 | $10,039,340 | $9,099,224 | -$940,116 | -9.36% | |
| Vanguard Portfolio Management Llc | 0.00% | 669,895 | $9,800,564 | $8,882,808 | -$917,756 | -9.36% | |
| Dcf Advisers, Llc | 3.52% | 637,500 | $9,326,625 | $8,453,250 | -$873,375 | -9.36% | |
| Eventide Asset Management, Llc | 0.13% | 550,000 | $8,046,500 | $7,293,000 | -$753,500 | -9.36% | |
| Marshall Wace, Llp | 0.01% | 548,285 | $8,021,410 | $7,270,259 | -$751,151 | -9.36% | |
| Blue Owl Capital Holdings Lp | 2.14% | 545,000 | $7,973,350 | $7,226,700 | -$746,650 | -9.36% | |
| Two Sigma Investments, Lp | 0.01% | 539,869 | $7,898,283 | $7,158,663 | -$739,620 | -9.36% | |
| Northern Trust Corp | 0.00% | 506,104 | $7,404,301 | $6,710,939 | -$693,362 | -9.36% | |
| Vanguard Fiduciary Trust Co | 0.00% | 504,631 | $7,382,752 | $6,691,407 | -$691,345 | -9.36% | |
| Emerald Mutual Fund Advisers Trust | 0.33% | 459,253 | $6,718,871 | $6,089,695 | -$629,176 | -9.36% | |
| Logos Global Management Lp | 0.34% | 450,000 | $6,583,500 | $5,967,000 | -$616,500 | -9.36% | |
| Nextech Invest, Ltd. | 0.46% | 450,000 | $6,583,500 | $5,967,000 | -$616,500 | -9.36% | |
| Ra Capital Management, L.P. | 0.07% | 450,000 | $6,583,500 | $5,967,000 | -$616,500 | -9.36% | |
| Citadel Advisors Llc | 0.00% | 442,522 | $6,474,097 | $5,867,842 | -$606,255 | -9.36% | |
| Ubs Group Ag | 0.00% | 289,114 | $4,229,738 | $3,833,652 | -$396,086 | -9.36% | |
| Voloridge Investment Management, Llc | 0.02% | 278,007 | $4,067,242 | $3,686,373 | -$380,869 | -9.36% | |
| Sphera Funds Management Ltd. | 0.62% | 247,961 | $3,627,669 | $3,287,963 | -$339,706 | -9.36% | |
| Diadema Partners Lp | 1.48% | 244,811 | $3,581,585 | $3,246,194 | -$335,391 | -9.36% | |
| Barclays Plc | 0.00% | 243,776 | $3,566,444 | $3,232,470 | -$333,974 | -9.36% | |
| Bank Of America Corp | 0.00% | 237,004 | $3,467,368 | $3,142,673 | -$324,695 | -9.36% | |
| Spruce Street Capital Lp | 0.81% | 231,585 | $3,388,089 | $3,070,817 | -$317,272 | -9.36% | |
| Seb Asset Management Ab | 0.01% | 226,837 | $3,318,621 | $3,007,859 | -$310,762 | -9.36% | |
| Charles Schwab Investment Management Inc | 0.00% | 188,129 | $2,752,327 | $2,494,591 | -$257,736 | -9.36% | |
| Bank Of New York Mellon Corp | 0.00% | 185,347 | $2,711,630 | $2,457,701 | -$253,929 | -9.36% | |
| Polymer Capital Management (Hk) Ltd | 0.38% | 183,187 | $2,680,026 | $2,429,060 | -$250,966 | -9.36% | |
| Brevan Howard Capital Management Lp | 0.02% | 167,971 | $2,457,416 | $2,227,295 | -$230,121 | -9.36% | |
| Nuveen, Llc | 0.00% | 149,126 | $2,181,713 | $1,977,411 | -$204,302 | -9.36% | |
| Jump Financial, Llc | 0.03% | 147,850 | $2,163,045 | $1,960,491 | -$202,554 | -9.36% |
Frequently asked questions about CRVS
Who owns the most CRVS stock?
The largest holders of CRVS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CORVUS PHARMACEUTICALS INC (CRVS).
Is CRVS widely held by superinvestors?
Many widely followed stocks like CRVS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CRVS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.